Park National Corp OH Boosts Stock Holdings in Danaher Corporation $DHR

Posted by Francis Steltz on Jun 21st, 2026

Park National Corp OH raised its holdings in Danaher Corporation (NYSE:DHR – Free Report) by 10.8% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 82,269 shares of the conglomerate’s stock after purchasing an additional 7,998 shares during the quarter. Park National Corp OH’s holdings in Danaher were worth $15,598,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. JPL Wealth Management LLC purchased a new stake in shares of Danaher in the third quarter valued at approximately $25,000. Elevated Capital Advisors LLC acquired a new position in Danaher during the fourth quarter worth $26,000. WFA of San Diego LLC purchased a new position in Danaher in the second quarter worth $26,000. ANTIPODES PARTNERS Ltd purchased a new position in Danaher in the third quarter worth $27,000. Finally, Hilton Head Capital Partners LLC acquired a new stake in Danaher in the fourth quarter valued at $27,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Up 0.3%

DHR opened at $177.74 on Friday. The business’s fifty day moving average is $179.62 and its two-hundred day moving average is $203.07. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. The company has a market cap of $125.80 billion, a price-to-earnings ratio of 34.38, a PEG ratio of 2.26 and a beta of 0.81. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80.

Danaher (NYSE:DHR – Get Free Report) last posted its earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, beating the consensus estimate of $1.94 by $0.12. The company had revenue of $5.95 billion for the quarter, compared to analyst estimates of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.Danaher’s revenue was up 3.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.88 earnings per share. Analysts anticipate that Danaher Corporation will post 8.45 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio is presently 30.95%.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on DHR shares. Argus decreased their target price on shares of Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research report on Friday, April 24th. Weiss Ratings reiterated a “hold (c)” rating on shares of Danaher in a report on Friday, March 27th. Barclays reduced their price objective on shares of Danaher from $250.00 to $230.00 and set an “overweight” rating for the company in a research note on Tuesday, April 14th. DZ Bank started coverage on shares of Danaher in a report on Wednesday, June 3rd. They set a “buy” rating and a $210.00 price objective on the stock. Finally, Jefferies Financial Group restated a “buy” rating and set a $245.00 target price on shares of Danaher in a research report on Tuesday, April 21st. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $233.61.

Read Our Latest Stock Report on Danaher

Danaher Company Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.